Watson Pharmaceuticals, Inc. , a leading specialty pharmaceutical company, announced today that its subsidiary has commenced commercial shipment of its Omeprazole Delayed-Release Capsules USP product in the 40mg strength from its Davie, Florida manufacturing facility. In conjunction with the launch, Watson has 180 days of marketing exclusivity for being the first to file an ANDA containing a paragraph IV certification for the 40mg strength.
The details can be read here.
2 comments:
Any info on the Lupin launch of Depakote ER? Why not the plain formula first....
There is no tentative approval for Lupin of Depakote ER. The plain formula is not approved. Depakote is approved in DR and ER only.
I think this will solve your query. Please feel free to get back in case of any further query.
Post a Comment